FUNDRAISING FOR A CURE
Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them
Scientists in Southampton are developing a new way of delivering chemotherapy directly to cancer cells, with the aim of reducing its impact on healthy tissue.
Project Expedite, led by Dr Emre Sayan, an associate professor at the University of Southampton, involves using tiny particles called exosomes to carry chemotherapy drugs directly to cancer cells.
Funded by PLANETS Cancer Charity, the research could ultimately be used to treat cancers including pancreatic, gastric, liver, colorectal and neuroendocrine tumours.
The approach targets ROR1, a protein found at high levels in a number of cancer types but with limited expression in normal adult tissues. Researchers are engineering exosomes to recognise ROR1 and carry chemotherapy to cancer cells expressing the protein.
The team has already demonstrated proof-of-concept in the laboratory, developing the targeted exosomes and a method of loading chemotherapy into them. Early results have shown activity against cancer cells, including cells resistant to chemotherapy.
Over the next 18 months, researchers aim to test the safety and effectiveness of the approach in advanced cancer models and generate the regulatory-grade preclinical data needed to support future progression towards the first human studies.
“The idea is to develop a way of carrying chemotherapy directly to cancer cells rather than exposing healthy cells throughout the body to the drug,” said Dr Sayan.
“You can think of it almost like a guided missile. We are engineering exosomes to recognise ROR1 on cancer cells, seek out their target and deliver the chemotherapy where it is needed.
“We have demonstrated proof-of-concept in the laboratory and the early results are encouraging, including in cancer cells resistant to chemotherapy.
“There is still significant work ahead, but the next 18 months will be about generating the evidence needed to support future progression towards studies in patients.”
PLANETS Cancer Charity has committed £90,000 to support Project Expedite as part of its work to develop new treatment options for patients with some of the most difficult-to-treat cancers.
Layla Stephen, director of strategy and finance at PLANETS Cancer Charity, said: “Supporting research into better treatment options for our patients is at the heart of what PLANETS does.
“Many of the people we support are living with cancers where treatment options can become very limited.
“Project Expedite is exploring a completely new way of delivering an established cancer treatment, and we are proud to be supporting Emre and his team as they take that research forward.”
James Thorpe (pictured below), 49, from Chichester, who has been treated for neuroendocrine cancer and recently met Dr Sayan to learn about the research, said: “When I met Emre and heard about his research, hope was the overwhelming feeling I came away with.
“Hearing about the work being done to develop new approaches to cancer treatment gives patients like me hope for what may be possible in the future.”
Project Expedite has also received a £10,000 grant from the Hospital Saturday Fund towards the next stage of laboratory research.
John Greenwood, Chairman of the Hospital Saturday Fund, and Katie Newberrie, Charity Co-ordinator, visited University Hospital Southampton recently to meet Dr Sayan and learn more about the project.
The research remains at a preclinical stage and further testing will be required before the technology could be studied in patients.
READ ABOUT HOW FUNDS ARE USED
Subscribe to our Newsletter
Get informed about the latest news straight to your inbox


